{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:35:15Z","timestamp":1769513715195,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"am","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.oret.2023.01.001","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T12:52:24Z","timestamp":1672923144000},"page":"532-542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cost-effectiveness Analysis of a Personalized, Teleretinal-Inclusive Screening Policy for Diabetic Retinopathy via Markov Modeling"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1736-1008","authenticated-orcid":false,"given":"Poria","family":"Dorali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1419-681X","authenticated-orcid":false,"given":"Zahed","family":"Shahmoradi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3135-1922","authenticated-orcid":false,"given":"Christina Y.","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taewoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2023.01.001_bib1","doi-asserted-by":"crossref","first-page":"s99","DOI":"10.2337\/diacare.26.2007.S99","article-title":"Diabetic retinopathy","volume":"26","author":"Fong","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.oret.2023.01.001_bib3","first-page":"1","article-title":"Eye disorders and vision loss among US adults aged 45 and over with diagnosed diabetes, 2016\u20132017","volume":"344","author":"Cha","year":"2019","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.oret.2023.01.001_bib4","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/jama.1993.03500100088034","article-title":"How effective are treatments for diabetic retinopathy?","volume":"269","author":"Ferris","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.oret.2023.01.001_bib5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.7326\/0003-4819-124-1_Part_2-199601011-00017","article-title":"Cost-effectiveness of detecting and treating diabetic retinopathy","volume":"124","author":"Javitt","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.oret.2023.01.001_bib6","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/jama.283.7.889","article-title":"Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus","volume":"283","author":"Vijan","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.oret.2023.01.001_bib7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2337\/dc16-2641","article-title":"Diabetic retinopathy: a position statement by the American Diabetes Association","volume":"40","author":"Solomon","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.oret.2023.01.001_bib8","doi-asserted-by":"crossref","first-page":"P66","DOI":"10.1016\/j.ophtha.2019.09.025","article-title":"Diabetic retinopathy preferred practice pattern","volume":"127","author":"Flaxel","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2023.01.001_bib9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1001\/jamaophthalmol.2015.5083","article-title":"Evaluation of automated teleretinal screening program for diabetic retinopathy","volume":"134","author":"Walton","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2023.01.001_bib10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jamaophthalmol.2013.6046","article-title":"Eye care use among a high-risk diabetic population seen in a public hospital\u2019s clinics","volume":"132","author":"MacLennan","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2023.01.001_bib11","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.ophtha.2006.04.018","article-title":"Noncompliance with vision care guidelines in Latinos with type 2 diabetes mellitus: the Los Angeles Latino eye study","volume":"113","author":"Paz","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2023.01.001_bib12","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.ophtha.2019.05.033","article-title":"Characteristics associated with adherence to annual dilated eye examinations among US patients with diagnosed diabetes","volume":"126","author":"Eppley","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2023.01.001_bib13","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.oret.2018.01.020","article-title":"Cost savings analysis for a diabetic retinopathy teleretinal screening program using an activity-based costing approach","volume":"2","author":"Garoon","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2023.01.001_bib14","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jamainternmed.2017.0204","article-title":"Implementation and evaluation of a large-scale teleretinal diabetic retinopathy screening program in the Los Angeles County Department of Health Services","volume":"177","author":"Daskivich","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.oret.2023.01.001_bib16","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1016\/j.ophtha.2013.06.029","article-title":"Evaluation of telemedicine for screening of diabetic retinopathy in the Veterans Health Administration","volume":"120","author":"Kirkizlar","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2023.01.001_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/IIO.0000000000000246","article-title":"Applications of deep learning and artificial intelligence in retina","volume":"59","author":"Date","year":"2019","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.oret.2023.01.001_bib18","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2337\/diacare.27.5.1095","article-title":"Cost-effectiveness analysis of telemedicine to evaluate diabetic retinopathy in a prison population","volume":"27","author":"Aoki","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.oret.2023.01.001_bib19","doi-asserted-by":"crossref","first-page":"e1146","DOI":"10.1111\/aos.14745","article-title":"Cost-effectiveness of dexamethasone and triamcinolone for the treatment of diabetic macular edema in Finland: A Markov-model","volume":"99","author":"Pesonen","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oret.2023.01.001_bib20","doi-asserted-by":"crossref","first-page":"e968","DOI":"10.1016\/S2214-109X(19)30201-3","article-title":"Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model","volume":"7","author":"Tang","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.oret.2023.01.001_bib21","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1001\/jamaophthalmol.2019.4284","article-title":"Five-year cost-effectiveness of intravitreous ranibizumab therapy vs panretinal photocoagulation for treating proliferative diabetic retinopathy: a secondary analysis of a randomized clinical trial","volume":"137","author":"Hutton","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2023.01.001_bib22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jamaophthalmol.2022.0223","article-title":"Cost-effectiveness of artificial intelligence\u2013based retinopathy of prematurity screening","volume":"140","author":"Morrison","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2023.01.001_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.artmed.2012.12.003","article-title":"Artificial intelligence framework for simulating clinical decision-making: A Markov decision process approach","volume":"57","author":"Bennett","year":"2013","journal-title":"Artif Intel Med"},{"key":"10.1016\/j.oret.2023.01.001_bib24","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: Second Panel on Cost-Effectiveness in Health and Medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.oret.2023.01.001_bib25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.oret.2018.12.003","article-title":"Accuracy of detection and grading of diabetic retinopathy and diabetic macular edema using teleretinal screening","volume":"3","author":"Date","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2023.01.001_bib26","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.3928\/23258160-20200401-01","article-title":"Social cost of blindness due to AMD and diabetic retinopathy in the United States in 2020","volume":"51","author":"Moshfeghi","year":"2020","journal-title":"Ophthalmic Surg, Lasers Imaging Retina"},{"key":"10.1016\/j.oret.2023.01.001_bib27","article-title":"Factors associated with follow-up examination following positive teleretinal screening for diabetic retinopathy in an urban healthcare system","author":"Chamberlain","year":"2018","journal-title":"Dissertation"},{"key":"10.1016\/j.oret.2023.01.001_bib28","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/0272989X9301300409","article-title":"Markov models in medical decision making: a practical guide","volume":"13","author":"Sonnenberg","year":"1993","journal-title":"Med Decis Making"},{"key":"10.1016\/j.oret.2023.01.001_bib30","article-title":"Factors influencing patient adherence with diabetic eye screening in rural communities: a qualitative study","volume":"13","author":"Liu","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.oret.2023.01.001_bib31","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.oret.2020.12.006","article-title":"Geographic access disparities to clinical trials in diabetic eye disease in the United States","volume":"5","author":"Soares","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2023.01.001_bib32","series-title":"Screening for diabetic retinopathy in James Bay","first-page":"160","volume":"168","author":"Maberley","year":"2003"},{"key":"10.1016\/j.oret.2023.01.001_bib33","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.2337\/diacare.25.12.2224","article-title":"Adherence to American Diabetes Association standards of care by rural health care providers","volume":"25","author":"Coon","year":"2002","journal-title":"Diab Care"},{"key":"10.1016\/j.oret.2023.01.001_bib34","first-page":"52","article-title":"Cost-savings analysis of telemedicine use for ophthalmic screening in a rural Appalachian health clinic","volume":"109","author":"Richardson","year":"2013","journal-title":"W\u00a0V Med J"},{"key":"10.1016\/j.oret.2023.01.001_bib35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3129\/i09-220","article-title":"The prevalence of diabetic retinopathy as identified by teleophthalmology in rural Alberta","volume":"45","author":"Nathoo","year":"2010","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.oret.2023.01.001_bib36","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.ophtha.2018.04.007","article-title":"Guidelines on diabetic eye care: the International Council of Ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings","volume":"125","author":"Wong","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2023.01.001_bib37","doi-asserted-by":"crossref","first-page":"e615","DOI":"10.1161\/CIR.0000000000000753","article-title":"Call to action: rural health: a presidential advisory from the American Heart Association and American Stroke Association","volume":"141","author":"Harrington","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.oret.2023.01.001_bib38","first-page":"365","article-title":"Diabetes care and outcomes: disparities across rural America","volume":"35","author":"Hale","year":"2010","journal-title":"J\u00a0Community Health"},{"key":"10.1016\/j.oret.2023.01.001_bib39","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3109\/08820538.2016.1154170","article-title":"Disparities in adherence to screening guidelines for diabetic retinopathy in the United States: a comprehensive review and guide for future directions","volume":"31","author":"Fathy","year":"2016","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.oret.2023.01.001_bib40","article-title":"Location-based analysis on optimizing teleretinal imaging accessibility in a large safety-net system","volume":"62","author":"Dorali","year":"2021","journal-title":"Investig Ophthalmol Vis Sci"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653023000015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653023000015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:31:32Z","timestamp":1762853492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653023000015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2468653023000015"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2023.01.001","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness Analysis of a Personalized, Teleretinal-Inclusive Screening Policy for Diabetic Retinopathy via Markov Modeling","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2023.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}